WealthBridge Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
WealthBridge Capital Management's PFE Position: Q4 2024 in Review
WealthBridge Capital Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 7,597 shares — an estimated $220K sold.
WealthBridge Capital Management first reported a position in PFE in Q4 2018 and held it in 21 quarters. The position peaked at $856K in Q3 2022. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- WealthBridge Capital Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
- WealthBridge Capital Management sold 7,597 Pfizer shares in Q4 2024, an estimated $220K.
- WealthBridge Capital Management first reported a position in Pfizer in Q4 2018 and held it in 21 quarters.
- WealthBridge Capital Management's Pfizer position peaked at $856K in Q3 2022.
- 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on WealthBridge Capital Management's 13F filing for Q4 2024, filed 3 Feb 2025.